Sebastián-Morelló, M.; Alambiaga-Caravaca, A.M.; Calatayud-Pascual, M.A.; Rodilla, V.; Balaguer-Fernández, C.; Miranda, M.; López-Castellano, A.
Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases. Pharmaceutics 2020, 12, 861.
https://doi.org/10.3390/pharmaceutics12090861
AMA Style
Sebastián-Morelló M, Alambiaga-Caravaca AM, Calatayud-Pascual MA, Rodilla V, Balaguer-Fernández C, Miranda M, López-Castellano A.
Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases. Pharmaceutics. 2020; 12(9):861.
https://doi.org/10.3390/pharmaceutics12090861
Chicago/Turabian Style
Sebastián-Morelló, MarÃa, Adrián M. Alambiaga-Caravaca, MarÃa Aracely Calatayud-Pascual, Vicent Rodilla, Cristina Balaguer-Fernández, MarÃa Miranda, and Alicia López-Castellano.
2020. "Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases" Pharmaceutics 12, no. 9: 861.
https://doi.org/10.3390/pharmaceutics12090861
APA Style
Sebastián-Morelló, M., Alambiaga-Caravaca, A. M., Calatayud-Pascual, M. A., Rodilla, V., Balaguer-Fernández, C., Miranda, M., & López-Castellano, A.
(2020). Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases. Pharmaceutics, 12(9), 861.
https://doi.org/10.3390/pharmaceutics12090861